Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Epithelium Of Left Lung, Non-small Cell Lung Cancer Cell Line
DISEASE(S): Non-small Cell Lung Carcinoma
SUBMITTER:
Yue Gao
LAB HEAD: Tao Wang
PROVIDER: PXD067541 | Pride | 2025-12-01
REPOSITORIES: Pride
| Action | DRS | |||
|---|---|---|---|---|
| checksum.txt | Txt | |||
| original.zip | Other | |||
| sdrf.tsv | Tabular | |||
| search.zip | Other |
Items per page: 1 - 4 of 4 |

Cell death discovery 20251121 1
Repurposing existing drugs offers a promising approach to cancer therapy. Fosinopril, an angiotensin converting enzyme inhibitor (ACEI) approved for hypertension, has demonstrated antitumor effects in hepatocellular carcinoma. However, its activity in non-small cell lung cancer (NSCLC) remains poorly understood. Here, we explore the potential anti-NSCLC effects of fosinopril in vitro and in vivo and its action mechanisms. The antiproliferative effects of fosinopril on NSCLC cells were assessed t ...[more]